FDA proposes new system for approving customized drugs and therapies for rare diseases - The Food and Drug Administration is proposing a system for approving customized drugs and medical treatments fo ...

Humans have been shaping life for thousands of years through farming, breeding, and selective cultivation. But with modern tools like CRISPR, we can now directly edit DNA itself—rewriting the very ...

CNBC's Becky Quick reports on the progress of KJ Muldoon, the first patient to receive a personalized CRISPR-based gene editing therapy.

Last year’s federal agency layoffs, grant discontinuations, and university funding cuts led to numerous warnings of the disastrous impact on U.S. science research. Gretchen Goldman, PhD, from the ...

If you never eat grapefruit because you find them far too bitter, CRISPR varieties may be more to your taste. It has been shown that disabling one gene via gene editing can greatly reduce the level of ...

Oil prices rose sharply when market trading began late Sunday over concerns that the supply from Iran and elsewhere in the ...

Antibiotic resistance (AR) has steadily accelerated in recent years to become a global health crisis. As deadly bacteria evolve new ways to elude drug treatments for a variety of illnesses, a growing ...

Oceanic ecosystems are increasingly threatened by global warming, which causes coral bleaching, species migration and, through the loss of habitats and biodiversity, food web disruptions on major ...

Jason Mast is a general assignment reporter at STAT focused on the science behind new medicines and the systems and people that decide whether that science ever reaches patients. You can reach Jason ...

In May 2025, the world celebrated the success of KJ, an infant who was treated with the world’s first personalized CRISPR gene editing therapy. KJ was born with severe carbamoyl phosphate synthetase 1 ...